Clinical Roundup Phase III trial for Keytruda in lung cancer reaches dual primary endpoint of OS October 13, 2023Vol.49 No.38
Clinical Roundup Phase II study of BXCL701 + Keytruda in small cell neuroendocrine prostate cancer shows positive OS results October 13, 2023Vol.49 No.38
Clinical Roundup Hopkins phase II study suggests liquid biopsy could be early marker of immunotherapy response October 13, 2023Vol.49 No.38
Clinical Roundup Rural hospital system demonstrates clinical benefits of universal hereditary cancer testing in breast cancer October 13, 2023Vol.49 No.38
Clinical Roundup USC researchers develop blood test with the potential to detect early-stage ovarian cancer October 13, 2023Vol.49 No.38
Clinical Roundup City of Hope and TGen research reveals potential cause of aggressive leukemia October 13, 2023Vol.49 No.38
Clinical Roundup New antibody shows strong potential against pancreatic cancer October 13, 2023Vol.49 No.38
Clinical Roundup NYU Perlmutter research suggests drug combination could starve pancreatic cancer October 13, 2023Vol.49 No.38
Clinical Roundup Telomere-targeting agent demonstrates potent anticancer activity in aggressive pediatric brain cancer in preclinical study October 13, 2023Vol.49 No.38
Clinical Roundup NCCN: U.S. cancer centers continue to see chemotherapy shortages October 06, 2023Vol.49 No.37
